Gapping down
In reaction to disappointing earnings/guidance:
- ZFGN -27.2% (also suspends IND filing plans for ZGN-1258 based on nonclinical finding in long-term toxicology studies), ADT -13.7%, FRTA -6.5%, PETQ -5.5%, KRO -4.9%, KRO -4.8%, VHI -3.7%
M&A news:
- FFIV -2.5% (to acquire NGINX for a total enterprise value of approx. $670 mln; downgraded to Neutral from Overweight at JP Morgan)
Other news:
- TGLS -9.3% (commences underwritten follow-on public offering of 8 mln ordinary shares)
- EPRT -3.5% (announces public offering of 10.6 mln shares of common stock)
- ATUS -2.8% (attributed to block trade pricing)
- HLNE -1.5% (commences public offering of 1,449,303 shares of Class A common stock to be sold by Hamilton Lane and a selling stockholder)
Analyst comments:
- HPE -3.4% (downgraded to Sell from Neutral at UBS)
- UNFI -3% (downgraded to Underweight from Equal Weight at Barclays)
- BA -2.2% (downgraded to Hold from Buy at Edward Jones)
- TSLA -1.6% (target lowered to $260 from $283 at Morgan Stanley)
- MNST -1.2% (downgraded to Market Perform from Outperform at BMO Capital Markets)
- KO -0.6% (downgraded to Hold from Buy at HSBC Securities)